Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation

Aasheim, 2005, Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2, Blood, 105, 2869, 10.1182/blood-2004-08-2981

Baiocchi, 1991, Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies, Cancer, 67, 990, 10.1002/1097-0142(19910215)67:4<990::AID-CNCR2820670422>3.0.CO;2-8

Baker, 1994, Evidence that Ras and Myc mediate the synergy between SCF or M-CSF and other haemopoietic growth factors, Leukemia, 8, 1970

Bluman, 1996, The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction, Blood, 88, 3887, 10.1182/blood.V88.10.3887.bloodjournal88103887

Bollard, 2002, Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity, Blood, 99, 3179, 10.1182/blood.V99.9.3179

Boon, 1997, Tumor antigens recognized by T cells, Immunol. Today, 18, 267, 10.1016/S0167-5699(97)80020-5

Bourette, 2007, E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells, Oncogene, 26, 234, 10.1038/sj.onc.1209777

Brentjens, 2003, Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15, Nat. Med., 9, 279, 10.1038/nm827

Bubenik, 2004, MHC class I down-regulation: tumour escape from immune surveillance? (review), Int. J. Oncol., 25, 487

Byrd, 1999, Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kB in FGF receptor-bearing Jurkat T-cells, J. Immunol., 162, 5853, 10.4049/jimmunol.162.10.5853

Chow, 2001, Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors, Cytometry, 46, 72, 10.1002/cyto.1067

Crawley, 1996, Interleukin-7 induces T-cell proliferation in the absence of Erk/MAP kinase activity, Eur. J. Immunol., 26, 2717, 10.1002/eji.1830261125

Dibb, 1990, Expression of v-fms and c-fms in the hemopoietic cell line FDC-P1, Growth Factors, 2, 301, 10.3109/08977199009167025

Downing, 1989, Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms, Mol. Cell. Biol., 9, 2890, 10.1128/MCB.9.7.2890

Fantyl, 1993, Signaling by receptor tyrosine kinases, Ann. Rev. Biochem., 62, 453, 10.1146/annurev.bi.62.070193.002321

Friel, 2005, Diverse isoforms of colony-stimulating factor-1 have different effects on the development of stroma-dependent hematopoietic cells, J. Cell. Physiol., 204, 247, 10.1002/jcp.20291

Gajewski, 2006, Immune resistance orchestrated by the tumor microenvironment, Immunol. Rev., 213, 131, 10.1111/j.1600-065X.2006.00442.x

Goswami, 2005, Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop, Cancer Res., 65, 5278, 10.1158/0008-5472.CAN-04-1853

Hamilton, 1997, CSF-1 signal transduction, J. Leukoc. Biol., 62, 145, 10.1002/jlb.62.2.145

Haynes, 2002, Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors, Blood, 100, 3155, 10.1182/blood-2002-04-1041

Kacinski, 1997, CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract, Mol. Reprod. Dev., 46, 71, 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6

Kaminska, 2006, Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF—an independent prognostic factor, Oncology, 70, 115, 10.1159/000093002

Kershaw, 2006, A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer, Clin. Cancer Res., 12, 6106, 10.1158/1078-0432.CCR-06-1183

Kirma, 2007, Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression, Cancer Res., 67, 1918, 10.1158/0008-5472.CAN-06-1991

Kirma, 2004, Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation, Cancer Res., 64, 4162, 10.1158/0008-5472.CAN-03-2971

Kommoss, 1994, Co-expression of M-CSF transcripts and protein Fms (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary, J. Pathol., 174, 111, 10.1002/path.1711740207

Kouhara, 1997, A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway, Cell, 89, 693, 10.1016/S0092-8674(00)80252-4

Li, 2005, Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential, J. Immunol., 174, 4706, 10.4049/jimmunol.174.8.4706

Lin, 2006, Macrophages regulate the angiogenic switch in a mouse model of breast cancer, Cancer Res., 66, 11238, 10.1158/0008-5472.CAN-06-1278

Lin, 2001, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J. Exp. Med., 193, 727, 10.1084/jem.193.6.727

Lo, A.S.Y., Gorak-Stolinska, P., Bachy, V., Ibrahim, M.A., Kemeny, D.M., Maher, J. Modulation of dendritic cell differentiation by colony-stimulating factor-1: role of phosphatidylinositol 3′-kinase and delayed caspase activation. J. Leukoc. Biol., in press.

Maher, 2002, Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor, Nat. Biotechnol., 20, 70, 10.1038/nbt0102-70

McDermott, 2002, Circulating macrophage colony stimulating factor as a marker of tumour progression, Eur. Cytokine Netw., 13, 121

Menetrier-Caux, 1998, Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor, Blood, 92, 4778, 10.1182/blood.V92.12.4778

Morgan, 2006, Cancer regression in patients after transfer of genetically engineered lymphocytes, Science, 314, 126, 10.1126/science.1129003

Mroczko, 2007, Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis, Clin. Chim. Acta, 380, 208, 10.1016/j.cca.2007.02.037

Okazaki, 2005, Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis, J. Immunol., 174, 7531, 10.4049/jimmunol.174.12.7531

Pierce, 1990, Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA, Proc. Natl. Acad. Sci. U.S.A., 87, 5613, 10.1073/pnas.87.15.5613

Pule, 2005, A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells, Mol. Ther., 12, 933, 10.1016/j.ymthe.2005.04.016

Roche, 1994, The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors, Proc. Natl. Acad. Sci. U.S.A., 91, 9185, 10.1073/pnas.91.19.9185

Rosenberg, 2005, Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma, J. Immunol., 175, 6169, 10.4049/jimmunol.175.9.6169

Roussel, 1990, Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor, Mol. Cell. Biol., 10, 2407, 10.1128/MCB.10.5.2407

Sadelain, 2003, Targeting tumours with genetically enhanced T lymphocytes, Nat. Rev. Cancer, 3, 35, 10.1038/nrc971

Sapi, 2004, The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update, Exp. Biol. Med. (Maywood), 229, 1, 10.1177/153537020422900101

Skates, 2004, Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions, J. Clin. Oncol., 22, 4059, 10.1200/JCO.2004.03.091

Stanley, 1997, Biology and action of colony-stimulating factor-1, Mol. Reprod. Dev., 46, 4, 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V

Suzuki, 1995, Serum levels of macrophage colony-stimulating factor as a marker for gynecologic malignancies, Oncology, 52, 128, 10.1159/000227443

Takeda, 1996, Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa, Br. J. Cancer, 73, 615, 10.1038/bjc.1996.106

Taylor, 2006, FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance, Oncogene, 25, 147, 10.1038/sj.onc.1209007

Taylor, 2001, The Kit-activating mutation D816V enhances stem cell factor-dependent chemotaxis, Blood, 98, 1195, 10.1182/blood.V98.4.1195

Uden, 1999, Evidence that downregulation of the M-CSF receptor is not dependent upon receptor kinase activity, Oncogene, 18, 3846, 10.1038/sj.onc.1202743

van der Geer, 1991, Tyrosine 706 and 807 phosphorylation site mutants in the murine colony-stimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol-3 kinase but show differential defects in their ability to induce early response gene transcription, Mol. Cell. Biol., 11, 4698, 10.1128/MCB.11.9.4698

Vindis, 2003, EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis, J. Cell. Biol., 162, 661, 10.1083/jcb.200302073

von Rüden, 1991, Expression of human CSF-1 receptor induces CSF-1-dependent proliferation in murine myeloid but not in T-lymphoid cells, Leukemia, 5, 3

Xue, 2005, Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells, Blood, 106, 3062, 10.1182/blood-2005-01-0146

Yu, 2003, Ephrin B2 induces T cell costimulation, J. Immunol., 171, 106, 10.4049/jimmunol.171.1.106

Yu, 2004, Priming of naïve T cells inside tumors leads to eradication of established tumors, Nat. Immunol., 5, 141, 10.1038/ni1029